B2B
Ceptaris
United States
Ceptaris was a specialty pharmaceutical company that developed Valchlor, a proprietary gel formulation of mechlorethamine for treating early stage mycosis fungoides, a type of Cutaneous T-Cell Lymphom
acquiredacquired
acquired
Stage
About
Ceptaris was a specialty pharmaceutical company that developed Valchlor, a proprietary gel formulation of mechlorethamine for treating early stage mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL).
Explore Ceptaris's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.